Hitiq Limited

HIQ.ASX

Health Care

Building and commercialising a technology platform to assist in the surveillance, detection, assessment and diagnosis of sports related concussion injury.

Market Data

Price

$0.008

-0.1%
Market Cap

$6.4M

P/E Ratio

-100000.0x

EPS

$-0.014

Div. Yield

0.00%

52-Week Change

-0.7%

Latest Earnings

Half Year Report and Appendix 4D

25 February 2026

Revenue
$1.00
-3.2% YoY
NPAT
-$2.90
+6.2% YoY

HITIQ Limited reported a 3.2% decline in revenue to $997,178 for H1 FY26, but achieved a 6.2% improvement in net loss to $2.9M (vs $3.1M prior period). The company made significant strategic progress including Olympic validation, retail partnerships with Rebel Sport, and international expansion, though cash reserves remain critically low at $359K. Key points: Secured Olympic validation with 100 PROTEQT mouthguards for Winter Olympics deployment; Entered national retail distribution with Rebel Sport, Australia's leading sporting goods retailer; Launched North American expansion through exclusive Canadian distribution partnership

Recent Announcements

25 Feb 2026 Actual Results Neutral

Half Year Report and Appendix 4D

HITIQ Limited reported a 3.2% decline in revenue to $997,178 for H1 FY26, but achieved a 6.2% improvement in net loss to $2.9M (vs $3.1M prior period). The company made significant strategic progress including Olympic validation, retail partnerships with Rebel Sport, and international expansion, though cash reserves remain critically low at $359K. Key points: Secured Olympic validation with 100 PROTEQT mouthguards for Winter Olympics deployment; Entered national retail distribution with Rebel Sport, Australia's leading sporting goods retailer; Launched North American expansion through exclusive Canadian distribution partnership

Get real-time alerts for HIQ

Receive AI-powered earnings summaries and instant notifications when Hitiq Limited releases results.

Register Free